The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(abʹ)2 Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial

• Richard C. DartDenver Health Medical Center
• Sean P. BushLoma Linda University
• Kennon J HeardDenver Health Medical Center
• Thomas ArnoldLouisiana State University Health Sciences Center Shreveport
• Mark E. SutterUniversity of California Davis Medical Center
• Danielle D. CampagneUniversity of California, San Francisco
• Christopher P. HolstegeUniversity of Virginia Medical Center
• Steven A. SeifertUniversity of New Mexico Health Sciences Center
• Jean C.Y. LoLoma Linda University
• Dan QuanMaricopa Medical Center
• Stephen W. BorronTexas Tech University Health Sciences Center
• David A. MeurerUniversity of Florida Health
• Randy I. BurnhamDenver Health Medical Center
• Jude T. McNallyRare Disease Therapeutics (United States)
• Walter García-Ubbelohde
• Victoria E. AndersonDenver Health Medical Center